Mobile genetic element activation and genotoxic cancer therapy: Potential clinical implications

American journal of pharmacogenomics : genomics-related research in drug development and clinical practice

Volumn 2, Issue 1, 2002, Pages 25-35

  Hagan, Christy R ^a   Rudin, Charles M ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; MUTAGENIC AGENT;

DNA METHYLATION; GENETIC TRANSCRIPTION; HUMAN; REVIEW; SHORT INTERSPERSED REPEAT; TRANSPOSON;

ANTINEOPLASTIC AGENTS; DNA METHYLATION; DNA TRANSPOSABLE ELEMENTS; HUMANS; MUTAGENS; SHORT INTERSPERSED NUCLEOTIDE ELEMENTS; TRANSCRIPTION, GENETIC;

EID: 0036053548     PISSN: 11752203     EISSN: None     Source Type: Journal    
DOI: 10.2165/00129785-200202010-00003     Document Type: Review

References (105)

1. 1. MJ Ratain LS Kaminer JD Bitran 1987 Acute nonlymphocytic leukemia following etoposide and cisplatin combination chemotherapy for advanced non-small-cell carcinoma of the lung Blood 70 5 1412 7 2822173 1:STN:280:DyaL1c%2FisFGltw%3D%3D Nov Ratain MJ, Kaminer LS, Bitran JD, et al. Acute nonlymphocytic leukemia following etoposide and cisplatin combination chemotherapy for advanced non-small-cell carcinoma of the lung. Blood 1987 Nov; 70(5): 1412–7
2. 2. MA Tucker GJ D’Angio JD Boice Jr 1987 Bone sarcomas linked to radiotherapy and chemotherapy in children N Engl J Med 317 10 588 93 3475572 1:STN:280:DyaL2s3oslSktw%3D%3D 10.1056/NEJM198709033171002 Sep 3 Tucker MA, D’Angio GJ, Boice Jr JD, et al. Bone sarcomas linked to radiotherapy and chemotherapy in children. N Engl J Med 1987 Sep 3; 317(10): 588–93
3. 3. DL Darrington JM Vose JR Anderson 1994 Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies J Clin Oncol 12 12 2527 34 7989926 1:STN:280:DyaK2M%2FotFOruw%3D%3D Dec Darrington DL, Vose JM, Anderson JR, et al. Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies. J Clin Oncol 1994 Dec; 12(12): 2527–34
4. 4. A Rohatiner 1994 Myelodysplasia and acute myelogenous leukemia after myeloablative therapy with autologous stem-cell transplantation J Clin Oncol 12 12 2521 3 7989924 1:STN:280:DyaK2M%2FotFOrtQ%3D%3D Dec Rohatiner A. Myelodysplasia and acute myelogenous leukemia after myeloablative therapy with autologous stem-cell transplantation. J Clin Oncol 1994 Dec; 12(12): 2521–3
5. 5. LB Travis RE Curtis M Stovall 1994 Risk of leukemia following treatment for non-Hodgkin’s lymphoma J Natl Cancer Inst 86 19 1450 7 8089863 1:STN:280:DyaK2czns1eitw%3D%3D 10.1093/jnci/86.19.1450 Oct 5 Travis LB, Curtis RE, Stovall M, et al. Risk of leukemia following treatment for non-Hodgkin’s lymphoma. J Natl Cancer Inst 1994 Oct 5; 86(19): 1450–7
6. 6. RE Curtis PA Rowlings HG Deeg 1997 Solid cancers after bone marrow transplantation N Engl J Med 336 13 897 904 9070469 1:STN:280:DyaK2s3gvFCrtg%3D%3D 10.1056/NEJM199703273361301 Mar 27 Curtis RE, Rowlings PA, Deeg HG, et al. Solid cancers after bone marrow transplantation. N Engl J Med 1997 Mar 27; 336(13): 897–904
7. 7. HJ Deeg G Socie 1998 Malignancies after hematopoietic stem cell transplantation: many questions, some answers Blood 91 6 1833 44 9490664 1:CAS:528:DyaK1cXhvVCrt74%3D Mar 15 Deeg HJ, Socie G. Malignancies after hematopoietic stem cell transplantation: many questions, some answers. Blood 1998 Mar 15; 91(6): 1833–44
8. 8. SL Wolden KR Lamborn SF Cleary 1998 Second cancers following pediatric Hodgkin’s disease J Clin Oncol 16 2 536 44 9469338 1:STN:280:DyaK1c7ivFansg%3D%3D Feb Wolden SL, Lamborn KR, Cleary SF, et al. Second cancers following pediatric Hodgkin’s disease. J Clin Oncol 1998 Feb; 16(2): 536–44
9. 9. CA Felix 2001 Leukemias related to treatment with DNA topoisomerase II inhibitors Med Pediatr Oncol 36 5 525 35 11340607 1:STN:280:DC%2BD3MzgvFGitA%3D%3D 10.1002/mpo.1125 May Felix CA. Leukemias related to treatment with DNA topoisomerase II inhibitors. Med Pediatr Oncol 2001 May; 36(5): 525–35
10. 10. J Pedersen-Bjergaard P Philip 1991 Two different classes of therapy-related and denovo acute myeloid leukemia? Cancer Genet Cytogenet 55 1 119 24 1655239 1:STN:280:DyaK38%2FgsFeluw%3D%3D 10.1016/0165-4608(91)90246-Q Aug Pedersen-Bjergaard J, Philip P. Two different classes of therapy-related and denovo acute myeloid leukemia? Cancer Genet Cytogenet 1991 Aug; 55(1): 119–24
11. 11. MA Smith L Rubinstein JR Anderson 1999 Secondary leukemia or myelodysplastic syndrome after treatment with epipodophyllotoxins J Clin Oncol 17 2 569 77 10080601 1:CAS:528:DyaK1MXht1Wmu78%3D Feb Smith MA, Rubinstein L, Anderson JR,et al. Secondary leukemia or myelodysplastic syndrome after treatment with epipodophyllotoxins. J Clin Oncol 1999 Feb; 17(2): 569–77
12. 12. CH Pui RC Ribeiro ML Hancock 1991 Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia N Engl J Med 325 24 1682 7 1944468 1:STN:280:DyaK38%2FkvFKiuw%3D%3D 10.1056/NEJM199112123252402 Dec 12 Pui CH, Ribeiro RC, Hancock ML, et al. Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia. N Engl J Med 1991 Dec 12; 325(24): 1682–7
13. 13. KS Albain MM Beau Le R Ullirsch 1990 Implication of prior treatment with drug combinations including inhibitors of topoisomerase II in therapy-related monocytic leukemia with a 9;11 translocation Genes Chromosomes Cancer 2 1 53 8 2177642 1:STN:280:DyaK3M7itVequg%3D%3D 10.1002/gcc.2870020110 May Albain KS, Le Beau MM, Ullirsch R, et al. Implication of prior treatment with drug combinations including inhibitors of topoisomerase II in therapy-related monocytic leukemia with a 9;11 translocation. Genes Chromosomes Cancer 1990 May; 2(1): 53–8
14. 14. K Muratani T Hada Y Yamamoto 1991 Inactivation of the cholinesterase gene by Alu insertion: possible mechanism for human gene transposition Proc Natl Acad Sci U S A 88 24 11315 9 1662391 1:CAS:528:DyaK38Xhs1Omu7g%3D 10.1073/pnas.88.24.11315 Dec 15 Muratani K, Hada T, Yamamoto Y, et al. Inactivation of the cholinesterase gene by Alu insertion: possible mechanism for human gene transposition. Proc Natl Acad Sci U S A 1991 Dec 15; 88(24): 11315–9
15. 15. PD Aplan DS Chervinsky M Stanulla 1996 Site-specific DNA cleavage within the MLL breakpoint cluster region induced by topoisomerase II inhibitors Blood 87 7 2649 58 8639880 1:CAS:528:DyaK28XhvFeltrw%3D Apr 1 Aplan PD, Chervinsky DS, Stanulla M, et al. Site-specific DNA cleavage within the MLL breakpoint cluster region induced by topoisomerase II inhibitors. Blood 1996 Apr 1; 87(7): 2649–58
16. 16. PL Broeker HG Super MJ Thirman 1996 Distribution of 11 q23 breakpoints within the MLL breakpoint cluster region in de novo acute leukemia and in treatment-related acute myeloid leukemia: correlation with scaffold attachment regions and topoisomerase II consensus binding sites Blood 87 5 1912 22 8634439 1:STN:280:DyaK283gt1Gitw%3D%3D Mar 1 Broeker PL, Super HG, Thirman MJ, et al. Distribution of 11 q23 breakpoints within the MLL breakpoint cluster region in de novo acute leukemia and in treatment-related acute myeloid leukemia: correlation with scaffold attachment regions and topoisomerase II consensus binding sites. Blood 1996 Mar 1; 87(5): 1912–22
17. 17. DM Green A Hyland MP Barcos 2000 Second malignant neoplasms after treatment for Hodgkin’s disease in childhood or adolescence J Clin Oncol 18 7 1492 9 10735897 1:STN:280:DC%2BD3c3gtVGjsA%3D%3D Apr Green DM, Hyland A, Barcos MP, et al. Second malignant neoplasms after treatment for Hodgkin’s disease in childhood or adolescence. J Clin Oncol 2000 Apr; 18(7): 1492–9
18. 18. AJ Minn CM Rudin LH Boise 1995 Expression of bcl-xL can confer a multidrug resistance phenotype Blood 86 5 1903 10 7655019 1:CAS:528:DyaK2MXnslKru7w%3D Sep 1 Minn AJ, Rudin CM, Boise LH, et al. Expression of bcl-xL can confer a multidrug resistance phenotype. Blood 1995 Sep 1; 86(5): 1903–10
19. 19. CM Rudin CB Thompson 2001 Transcriptional activation of short interspersed elements by DNA-damaging agents Genes Chromosomes Cancer 30 1 64 71 11107177 1:CAS:528:DC%2BD3MXhtFyiug%3D%3D 10.1002/1098-2264(2000)9999:9999<::AID-GCC1066>3.0.CO;2-F Jan Rudin CM, Thompson CB. Transcriptional activation of short interspersed elements by DNA-damaging agents. Genes Chromosomes Cancer 2001 Jan; 30(1): 64–71
20. 20. PL Deininger MA Batzer 1999 Alu repeats and human disease Mol Genet Metab 67 3 183 93 10381326 1:CAS:528:DyaK1MXjvFWrtr4%3D 10.1006/mgme.1999.2864 Jul Deininger PL, Batzer MA. Alu repeats and human disease. Mol Genet Metab 1999 Jul; 67(3): 183–93
21. 21. AJ Mighell AF Markham PA Robinson 1997 Alu sequences FEBS Lett 417 1 1 5 9395063 1:CAS:528:DyaK2sXntVOhs7c%3D 10.1016/S0014-5793(97)01259-3 Nov 3 Mighell AJ, Markham AF, Robinson PA. Alu sequences. FEBS Lett 1997 Nov 3; 417(1): 1–5
22. 22. C Duncan PA Biro PV Choudary 1979 RNA polymerase III transcriptional units are interspersed among human non-alpha-globin genes Proc Natl Acad Sci U S A 76 10 5095 9 388428 1:CAS:528:DyaL3cXitVWh 10.1073/pnas.76.10.5095 Oct Duncan C, Biro PA, Choudary PV, et al. RNA polymerase III transcriptional units are interspersed among human non-alpha-globin genes. Proc Natl Acad Sci U S A 1979 Oct; 76(10): 5095–9
23. 23. SA Fuhrman PL Deininger P LaPorte 1981 Analysis of transcription of the human Alu family ubiquitous repeating element by eukaryotic RNA polymerase III Nucleic Acids Res 9 23 6439 56 6275362 1:CAS:528:DyaL38Xks12msg%3D%3D 10.1093/nar/9.23.6439 Dec 11 Fuhrman SA, Deininger PL, LaPorte P, et al. Analysis of transcription of the human Alu family ubiquitous repeating element by eukaryotic RNA polymerase III. Nucleic Acids Res 1981 Dec 11; 9(23): 6439–56
24. 24. WR Jelinek TP Toomey L Leinwand 1980 Ubiquitous, interspersed repeated sequences in mammalian genomes Proc Natl Acad Sci U S A 77 3 1398 402 6246492 1:CAS:528:DyaL3cXhvFaqsbk%3D 10.1073/pnas.77.3.1398 Mar Jelinek WR, Toomey TP, Leinwand L, et al. Ubiquitous, interspersed repeated sequences in mammalian genomes. Proc Natl Acad Sci U S A 1980 Mar; 77(3): 1398–402
25. 25. E Ullu C Tschudi 1984 Alu sequences are processed 7SL RNA genes Nature 312 5990 171 2 6209580 1:CAS:528:DyaL2MXktVymtw%3D%3D 10.1038/312171a0 Nov Ullu E, Tschudi C. Alu sequences are processed 7SL RNA genes. Nature 1984 Nov; 312(5990): 171–2
26. 26. SL Mathias AF Scott HH Kazazian Jr 1991 Reverse transcriptase encoded by a human transposable element Science 254 5039 1808 10 1722352 1:CAS:528:DyaK38XhtVSlsrs%3D 10.1126/science.1722352 Dec 20 Mathias SL, Scott AF, Kazazian Jr HH, et al. Reverse transcriptase encoded by a human transposable element. Science 1991 Dec 20; 254(5039): 1808–10
27. 27. Q Feng JV Moran HH Kazazian Jr 1996 Human L1 retrotransposon encodes a conserved endonuclease required for retrotransposition Cell 87 5 905 16 8945517 1:CAS:528:DyaK28Xntlyru78%3D 10.1016/S0092-8674(00)81997-2 Nov 29 Feng Q, Moran JV, Kazazian Jr HH, et al. Human L1 retrotransposon encodes a conserved endonuclease required for retrotransposition. Cell 1996 Nov 29; 87(5): 905–16
28. 28. MA Martin T Bryan S Rasheed 1981 Identification and cloning of endogenous retroviral sequences present in human DNA Proc Natl Acad Sci U S A 78 8 4892 6 6272283 1:CAS:528:DyaL3MXlvVamsbs%3D 10.1073/pnas.78.8.4892 Aug Martin MA, Bryan T, Rasheed S, et al. Identification and cloning of endogenous retroviral sequences present in human DNA. Proc Natl Acad Sci U S A 1981 Aug; 78(8): 4892–6
29. 29. J Jurka 1997 Sequence patterns indicate an enzymatic involvement in integration of mammalian retroposons Proc Natl Acad Sci U S A 94 5 1872 7 9050872 1:CAS:528:DyaK2sXhslaqtLo%3D 10.1073/pnas.94.5.1872 Mar 4 Jurka J. Sequence patterns indicate an enzymatic involvement in integration of mammalian retroposons. Proc Natl Acad Sci U S A 1997 Mar 4; 94(5): 1872–7
30. 30. AF Smit 1996 The origin of interspersed repeats in the human genome Curr Opin Genet Dev 6 6 743 8 8994846 1:CAS:528:DyaK2sXhsVWmtA%3D%3D 10.1016/S0959-437X(96)80030-X Dec Smit AF. The origin of interspersed repeats in the human genome. Curr Opin Genet Dev 1996 Dec; 6(6): 743–8
31. 31. HH Kazazian Jr 2000 Genetics. L1 retrotransposons shape the mammalian genome Science 289 5482 1152 3 10970230 1:CAS:528:DC%2BD3cXmt1Wjurk%3D 10.1126/science.289.5482.1152 Aug 18 Kazazian Jr HH. Genetics. L1 retrotransposons shape the mammalian genome. Science 2000 Aug 18; 289(5482): 1152–3
32. 32. DM Sassaman BA Dombroski JV Moran 1997 Many human L1 elements are capable of retrotransposition Nat Genet 16 1 37 43 9140393 1:CAS:528:DyaK2sXivFKhsLY%3D 10.1038/ng0597-37 May Sassaman DM, Dombroski BA, Moran JV, et al. Many human L1 elements are capable of retrotransposition. Nat Genet 1997 May; 16(1): 37–43
33. 33. AF Smit G Toth AD Riggs 1995 Ancestral, mammalian-wide subfamilies of LINE-1 repetitive sequences J Mol Biol 246 3 401 17 7877164 1:CAS:528:DyaK2MXktV2mtbg%3D 10.1006/jmbi.1994.0095 Feb 24 Smit AF, Toth G, Riggs AD, et al. Ancestral, mammalian-wide subfamilies of LINE-1 repetitive sequences. J Mol Biol 1995 Feb 24; 246(3): 401–17
34. 34. VO Kolosha SL Martin 1997 In vitro properties of the first ORF protein from mouse LINE-1 support its role in ribonucleoprotein particle formation during retro-transposition Proc Natl Acad Sci U S A 94 19 10155 60 9294179 1:CAS:528:DyaK2sXmt1Gjsr8%3D 10.1073/pnas.94.19.10155 Sep 16 Kolosha VO, Martin SL. In vitro properties of the first ORF protein from mouse LINE-1 support its role in ribonucleoprotein particle formation during retro-transposition. Proc Natl Acad Sci U S A 1997 Sep 16; 94(19): 10155–60
35. 35. H Hohjoh MF Singer 1997 Sequence-specific single-strand RNA binding protein encoded by the human LINE-1 retrotransposon EMBO J 16 19 6034 43 9312060 1:CAS:528:DyaK2sXntVKgsbo%3D 10.1093/emboj/16.19.6034 Oct 1 Hohjoh H, Singer MF. Sequence-specific single-strand RNA binding protein encoded by the human LINE-1 retrotransposon. EMBO J 1997 Oct 1; 16(19): 6034–43
36. 36. SL Martin FD Bushman 2001 Nucleic acid chaperone activity of the ORF1 protein from the mouse LINE-1 retrotransposon Mol Cell Biol 21 2 467 75 11134335 1:CAS:528:DC%2BD3MXhsFyhtLo%3D 10.1128/MCB.21.2.467-475.2001 Jan Martin SL, Bushman FD. Nucleic acid chaperone activity of the ORF1 protein from the mouse LINE-1 retrotransposon. Mol Cell Biol 2001 Jan; 21(2): 467–75
37. 37. AM Weiner 2000 Do all SINEs lead to LINEs? Nat Genet 24 4 332 3 10742088 1:CAS:528:DC%2BD3cXisVCjsLw%3D 10.1038/74135 Apr Weiner AM. Do all SINEs lead to LINEs? Nat Genet 2000 Apr; 24(4): 332–3
38. 38. JV Moran SE Holmes TP Naas 1996 High frequency retrotransposition in cultured mammalian cells Cell 87 5 917 27 8945518 1:CAS:528:DyaK28Xntlyqs70%3D 10.1016/S0092-8674(00)81998-4 Nov 29 Moran JV, Holmes SE, Naas TP, et al. High frequency retrotransposition in cultured mammalian cells. Cell 1996 Nov 29; 87(5): 917–27
39. 39. W Wei N Gilbert SL Ooi 2001 Human L1 retrotransposition: cis preference versus trans complementation Mol Cell Biol 21 4 1429 39 11158327 1:CAS:528:DC%2BD3MXovVClsA%3D%3D 10.1128/MCB.21.4.1429-1439.2001 Feb Wei W, Gilbert N, Ooi SL, et al. Human L1 retrotransposition: cis preference versus trans complementation. Mol Cell Biol 2001 Feb; 21(4): 1429–39
40. 40. H H Kazazian Jr JV Moran 1998 The impact of L1 retrotransposons on the human genome Nat Genet 19 1 19 24 9590283 1:CAS:528:DyaK1cXislWqurs%3D 10.1038/ng0598-19 May Kazazian, H. H., Jr, Moran JV. The impact of L1 retrotransposons on the human genome. Nat Genet 1998 May; 19(1): 19–24
41. 41. DD Luan MH Korman JL Jakubczak 1993 Reverse transcription of R2Bm RNA is primed by a nick at the chromosomal target site: a mechanism for non-LTR retrotransposition Cell 72 4 595 605 7679954 1:CAS:528:DyaK3sXhs1ansrc%3D 10.1016/0092-8674(93)90078-5 Feb 26 Luan DD, Korman MH, Jakubczak JL, et al. Reverse transcription of R2Bm RNA is primed by a nick at the chromosomal target site: a mechanism for non-LTR retrotransposition. Cell 1993 Feb 26; 72(4): 595–605
42. 42. CW Schmid 1998 Does SINE evolution preclude Alu function? Nucleic Acids Res 26 20 4541 50 9753719 1:CAS:528:DyaK1cXnt1Oks78%3D 10.1093/nar/26.20.4541 Oct 15 Schmid CW. Does SINE evolution preclude Alu function? Nucleic Acids Res 1998 Oct 15; 26(20): 4541–50
43. 43. JV Moran RJ DeBerardinis HH Kazazian Jr 1999 Exon shuffling by L1 retrotransposition Science 283 5407 1530 4 10066175 1:CAS:528:DyaK1MXhs1ymsb4%3D 10.1126/science.283.5407.1530 Mar 5 Moran JV, DeBerardinis RJ, Kazazian Jr HH. Exon shuffling by L1 retrotransposition. Science 1999 Mar 5; 283(5407): 1530–4
44. 44. WM Liu WM Chu PV Choudary 1995 Cell stress and translational inhibitors transiently increase the abundance of mammalian SINE transcripts Nucleic Acids Res 23 10 1758 65 7784180 1:CAS:528:DyaK2MXmsVOksL0%3D 10.1093/nar/23.10.1758 May 25 Liu WM, Chu WM, Choudary PV, et al. Cell stress and translational inhibitors transiently increase the abundance of mammalian SINE transcripts. Nucleic Acids Res 1995 May 25; 23(10): 1758–65
45. 45. TH Li C Kim CM Rubin 2000 K562 cells implicate increased chromatin accessibility in Alu transcriptional activation Nucleic Acids Res 28 16 3031 9 10931917 1:CAS:528:DC%2BD3cXmtVegtbs%3D 10.1093/nar/28.16.3031 Aug 15 Li TH, Kim C, Rubin CM, et al. K562 cells implicate increased chromatin accessibility in Alu transcriptional activation. Nucleic Acids Res 2000 Aug 15; 28(16): 3031–9
46. 46. B Panning JR Smiley 1994 Activation of RNA polymerase III transcription of human Alu elements by herpes simplex virus Virology 202 1 408 17 8009851 1:CAS:528:DyaK2cXktlahtLo%3D 10.1006/viro.1994.1357 Jul Panning B, Smiley JR. Activation of RNA polymerase III transcription of human Alu elements by herpes simplex virus. Virology 1994 Jul; 202(1): 408–17
47. 47. KL Jang DS Latchman 1989 HSV infection induces increased transcription of Alu repeated sequences by RNA polymerase III FEBS Lett 258 2 255 8 2557237 1:CAS:528:DyaK3cXnsVOhtQ%3D%3D 10.1016/0014-5793(89)81667-9 Dec 4 Jang KL, Latchman DS. HSV infection induces increased transcription of Alu repeated sequences by RNA polymerase III. FEBS Lett 1989 Dec 4; 258(2): 255–8
48. 48. VR Russanova CT Driscoll BH Howard 1995 Adenovirus type 2 preferentially stimulates polymerase III transcription of Alu elements by relieving repression: a potential role for chromatin Mol Cell Biol 15 8 4282 90 7623822 1:CAS:528:DyaK2MXntVGitL8%3D Aug Russanova VR, Driscoll CT, Howard BH. Adenovirus type 2 preferentially stimulates polymerase III transcription of Alu elements by relieving repression: a potential role for chromatin. Mol Cell Biol 1995 Aug; 15(8): 4282–90
49. 49. B Panning JR Smiley 1993 Activation of RNA polymerase III transcription of human Alu repetitive elements by adenovirus type 5: requirement for the Elb 58-kilodalton protein and the products of E4 open reading frames 3 and 6 Mol Cell Biol 13 6 3231 44 7684492 1:CAS:528:DyaK3sXltFSntL8%3D Jun Panning B, Smiley JR. Activation of RNA polymerase III transcription of human Alu repetitive elements by adenovirus type 5: requirement for the Elb 58-kilodalton protein and the products of E4 open reading frames 3 and 6. Mol Cell Biol 1993 Jun; 13(6): 3231–44
50. 50. DY Chang K Hsu RJ Maraia 1996 Monomeric scAlu and nascent dimeric Alu RNAs induced by adenovirus are assembled into SRP9/14-containing RNPs in HeLa cells Nucleic Acids Res 24 21 4165 70 8932367 1:CAS:528:DyaK28XntFyrt70%3D 10.1093/nar/24.21.4165 Nov 1 Chang DY, Hsu K, Maraia RJ. Monomeric scAlu and nascent dimeric Alu RNAs induced by adenovirus are assembled into SRP9/14-containing RNPs in HeLa cells. Nucleic Acids Res 1996 Nov 1; 24(21): 4165–70
51. 51. P Walter G Blobel 1982 Signal recognition particle contains a 7S RNA essential for protein translocation across the endoplasmic reticulum Nature 299 5885 691 8 6181418 1:CAS:528:DyaL3sXht1SmsLo%3D 10.1038/299691a0 Oct 21 Walter P, Blobel G. Signal recognition particle contains a 7S RNA essential for protein translocation across the endoplasmic reticulum. Nature 1982 Oct 21; 299(5885): 691–8
52. 52. O Weichenrieder K Wild K Strub 2000 Structure and assembly of the Alu domain of the mammalian signal recognition particle Nature 408 6809 167 73 11089964 1:STN:280:DC%2BD3M%2FkvVyisA%3D%3D 10.1038/35041507 Nov 9 Weichenrieder O, Wild K, Strub K, et al. Structure and assembly of the Alu domain of the mammalian signal recognition particle. Nature 2000 Nov 9; 408(6809): 167–73
53. 53. O Weichenrieder 2001 Hierarchical assembly of the Alu domain of the mammalian signal recognition particle RNA 7 5 731 40 11350037 1:CAS:528:DC%2BD3MXjsVensb8%3D 10.1017/S1355838201010160 May Weichenrieder O, et al. Hierarchical assembly of the Alu domain of the mammalian signal recognition particle. RNA 2001 May; 7(5): 731–40
54. 54. WM Liu RJ Maraia CM Rubin 1994 Alu transcripts: cytoplasmic localisation and regulation by DNA methylation Nucleic Acids Res 22 6 1087 95 7512262 1:CAS:528:DyaK2cXktVags70%3D 10.1093/nar/22.6.1087 Mar 25 Liu WM, Maraia RJ, Rubin CM, et al. Alu transcripts: cytoplasmic localisation and regulation by DNA methylation. Nucleic Acids Res 1994 Mar 25; 22(6): 1087–95
55. 55. U Hellmann-Blumberg MF Hintz JM Gatewood 1993 Developmental differences in methylation of human Alu repeats Mol Cell Biol 13 8 4523 30 8336699 1:CAS:528:DyaK3sXlvFOjt7s%3D Aug Hellmann-Blumberg U, Hintz MF, Gatewood JM, et al. Developmental differences in methylation of human Alu repeats. Mol Cell Biol 1993 Aug; 13(8): 4523–30
56. 56. IN Chesnokov CW Schmid 1995 Specific Alu binding protein from human sperm chromatin prevents DNA methylation J Biol Chem 270 31 18539 42 7629183 1:CAS:528:DyaK2MXntlCqu74%3D 10.1074/jbc.270.31.18539 Aug 4 Chesnokov IN, Schmid CW. Specific Alu binding protein from human sperm chromatin prevents DNA methylation. J Biol Chem 1995 Aug 4; 270(31): 18539–42
57. 57. GS Cox DW Gutkin MJ Haas 1998 Isolation of an Alu repetitive DNA binding protein and effect of CpG methylation on binding to its recognition sequence Biochim Biophys Acta 1396 1 67 87 9524225 1:CAS:528:DyaK1cXhslersr8%3D 10.1016/S0167-4781(97)00175-9 Mar 4 Cox GS, Gutkin DW, Haas MJ, et al. Isolation of an Alu repetitive DNA binding protein and effect of CpG methylation on binding to its recognition sequence. Biochim Biophys Acta 1998 Mar 4; 1396(1): 67–87
58. 58. W Doerfler 1983 DNA methylation and gene activity Annu Rev Biochem 52 93 124 6311083 1:CAS:528:DyaL3sXlsFaqtrs%3D 10.1146/annurev.bi.52.070183.000521 Doerfler W. DNA methylation and gene activity. Annu Rev Biochem 1983; 52: 93–124
59. 59. JR Graff JG Herman S Myohanen 1997 Mapping patterns of CpG island methylation in normal and neoplastic cells implicates both upstream and downstream regions in de novo methylation J Biol Chem 272 35 22322 9 9268383 1:CAS:528:DyaK2sXlslOls7o%3D 10.1074/jbc.272.35.22322 Aug 29 Graff JR, Herman JG, Myohanen S, et al. Mapping patterns of CpG island methylation in normal and neoplastic cells implicates both upstream and downstream regions in de novo methylation. J Biol Chem 1997 Aug 29; 272(35): 22322–9
60. 60. Y Koda M Soejima PH Johnson 2000 An Alu-mediated large deletion of the FUT2 gene in individuals with the ABO-Bombay phenotype Hum Genet 106 1 80 5 10982186 1:CAS:528:DC%2BD3cXhvVemsL4%3D 10.1007/s004390051013 Jan Koda Y, Soejima M, Johnson PH, et al. An Alu-mediated large deletion of the FUT2 gene in individuals with the ABO-Bombay phenotype. Hum Genet 2000 Jan; 106(1): 80–5
61. 61. MP Strout G Marcucci CD Bloomfield 1998 The partial tandem duplication of ALL1 (MLL) is consistently generated by Alu-mediated homologous recombination in acute myeloid leukemia Proc Natl Acad Sci U S A 95 5 2390 5 9482895 1:CAS:528:DyaK1cXhsleitbw%3D 10.1073/pnas.95.5.2390 Mar 3 Strout MP, Marcucci G, Bloomfield CD, et al. The partial tandem duplication of ALL1 (MLL) is consistently generated by Alu-mediated homologous recombination in acute myeloid leukemia. Proc Natl Acad Sci U S A 1998 Mar 3; 95(5): 2390–5
62. 62. CW So ZG Ma CM Price 1997 MLL self fusion mediated by Alu repeat homologous recombination and prognosis of AML-M4/M5 subtypes Cancer Res 57 1 117 22 8988051 1:CAS:528:DyaK2sXktVSrtA%3D%3D Jan 1 So CW, Ma ZG, Price CM, et al. MLL self fusion mediated by Alu repeat homologous recombination and prognosis of AML-M4/M5 subtypes. Cancer Res 1997 Jan 1; 57(1): 117–22
63. 63. SA Schichman MA Caliguiri MP Strout 1994 ALL-1 tandem duplication in acute myeloid leukemia with a normal karyotype involves homologous recombination between Alu elements Cancer Res 54 16 4277 80 8044771 1:CAS:528:DyaK2cXlvFOmsrg%3D Aug 15 Schichman SA, Caliguiri MA, Strout MP, et al. ALL-1 tandem duplication in acute myeloid leukemia with a normal karyotype involves homologous recombination between Alu elements. Cancer Res 1994 Aug 15; 54(16): 4277–80
64. 64. NJ Beauchamp M Makris FE Preston 2000 Major structural defects in the antithrombin gene in four families with type I antithrombin deficiency-partial/complete deletions and rearrangement of the antithrombin gene Thromb Haemost 83 5 715 21 10823268 1:CAS:528:DC%2BD3cXjsl2hsbs%3D May Beauchamp NJ, Makris M, Preston FE, et al. Major structural defects in the antithrombin gene in four families with type I antithrombin deficiency-partial/complete deletions and rearrangement of the antithrombin gene. Thromb Haemost 2000 May; 83(5): 715–21
65. 65. EM Rohlfs N Puget ML Graham 2000 An Alu-mediated 7.1 kb deletion of BRCA1 exons 8 and 9 in breast and ovarian cancer families that results in alternative splicing of exon 10 Genes Chromosomes Cancer 28 3 300 7 10862036 1:CAS:528:DC%2BD3cXks1SktL4%3D 10.1002/1098-2264(200007)28:3<300::AID-GCC8>3.0.CO;2-1 Jul Rohlfs EM, Puget N, Graham ML, et al. An Alu-mediated 7.1 kb deletion of BRCA1 exons 8 and 9 in breast and ovarian cancer families that results in alternative splicing of exon 10. Genes Chromosomes Cancer 2000 Jul; 28(3): 300–7
66. 66. A Petrij-Bosch T Peelen M Vliet van 1997 BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients Nat Genet 17 3 341 5 9354803 1:CAS:528:DyaK2sXntVSqtLk%3D 10.1038/ng1197-341 Nov Petrij-Bosch A, Peelen T, van Vliet M, et al. BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients. Nat Genet 1997 Nov; 17(3): 341–5
67. 67. N Puget D Torchard OM Serova-Sinilnikova 1997 A 1-kb Alu-mediated germ-line deletion removing BRCA1 exon 17 Cancer Res 57 5 828 31 9041180 1:CAS:528:DyaK2sXhs1Kju7c%3D Mar 1 Puget N, Torchard D, Serova-Sinilnikova OM, et al. A 1-kb Alu-mediated germ-line deletion removing BRCA1 exon 17. Cancer Res 1997 Mar 1; 57(5): 828–31
68. 68. R Suminaga Y Takeshima K Yasuda 2000 Non-homologous recombination between Alu and LINE-1 repeats caused a 430-kb deletion in the dystrophin gene: a novel source of genomic instability J Hum Genet 45 6 331 6 11185740 1:CAS:528:DC%2BD3cXos1yjs7g%3D 10.1007/s100380070003 Suminaga R, Takeshima Y, Yasuda K, et al. Non-homologous recombination between Alu and LINE-1 repeats caused a 430-kb deletion in the dystrophin gene: a novel source of genomic instability. J Hum Genet 2000; 45(6): 331–6
69. 69. M Hiltunen S Helisalmi A Mannermaa 2000 Identification of a novel 4.6-kb genomic deletion in presenilin-1 gene which results in exclusion of exon 9 in a Finnish early onset Alzheimer’s disease family: an Alu core sequence-stimulated recombination? Eur J Hum Genet 8 4 259 66 10854108 1:CAS:528:DC%2BD3cXktlGhsr0%3D 10.1038/sj.ejhg.5200423 Apr Hiltunen M, Helisalmi S, Mannermaa A, et al. Identification of a novel 4.6-kb genomic deletion in presenilin-1 gene which results in exclusion of exon 9 in a Finnish early onset Alzheimer’s disease family: an Alu core sequence-stimulated recombination? Eur J Hum Genet 2000 Apr; 8(4): 259–66
70. 70. J Zucman-Rossi MA Batzer M Stoneking 1997 Interethnic polymorphism of EWS intron 6: genome plasticity mediated by Alu retroposition and recombination Hum Genet 99 3 357 63 9050923 1:CAS:528:DyaK2sXitFSntrs%3D 10.1007/s004390050372 Mar Zucman-Rossi J, Batzer MA, Stoneking M, et al. Interethnic polymorphism of EWS intron 6: genome plasticity mediated by Alu retroposition and recombination. Hum Genet 1997 Mar; 99(3): 357–63
71. 71. X Cao KW Eu F Seow-Choen 2001 Topoisomerase-I-and Alu-mediated genomic deletions of the APC gene in familial adenomatous polyposis Hum Genet 108 5 436 42 11409872 1:CAS:528:DC%2BD3MXjvVGhtbg%3D 10.1007/s004390100492 May Cao X, Eu KW, Seow-Choen F, et al. Topoisomerase-I-and Alu-mediated genomic deletions of the APC gene in familial adenomatous polyposis. Hum Genet 2001 May; 108(5): 436–42
72. 72. FJ Chaves JT Real AB Garcia-Garcia 2001 Large rearrangements of the LDL receptor gene and lipid profile in a FH Spanish population Eur J Clin Invest 31 4 309 17 11298777 1:CAS:528:DC%2BD3MXjsVSjur0%3D 10.1046/j.1365-2362.2001.00823.x Apr Chaves FJ, Real JT, Garcia-Garcia AB, et al. Large rearrangements of the LDL receptor gene and lipid profile in a FH Spanish population. Eur J Clin Invest 2001 Apr; 31(4): 309–17
73. 73. MA Lehrman WJ Schneider TC Sudhof 1985 Mutation in LDL receptor: Alu-Alu recombination deletes exons encoding transmembrane and cytoplasmic domains Science 227 4683 140 6 3155573 1:CAS:528:DyaL2MXntlCrsw%3D%3D 10.1126/science.3155573 Jan 11 Lehrman MA, Schneider WJ, Sudhof TC, et al. Mutation in LDL receptor: Alu-Alu recombination deletes exons encoding transmembrane and cytoplasmic domains. Science 1985 Jan 11; 227(4683): 140–6
74. 74. M Centra E Memeo M d’Apolito 1998 Fine exon-intron structure of the Fanconi anemia group A (FAA) gene and characterization of two genomic deletions Genomics 51 3 463 7 9721219 1:CAS:528:DyaK1cXlvFSmsLo%3D 10.1006/geno.1998.5353 Aug 1 Centra M, Memeo E, d’Apolito M, et al. Fine exon-intron structure of the Fanconi anemia group A (FAA) gene and characterization of two genomic deletions. Genomics 1998 Aug 1; 51(3): 463–7
75. 75. N Rosenberg R Yatuv Y Orion 1997 Glanzmann thrombasthenia caused by an 11.2-kb deletion in the glycoprotein IIIa (beta3) is a second mutation in Iraqi Jews that stemmed from a distinct founder Blood 89 10 3654 62 9160670 1:CAS:528:DyaK2sXjt12ltL0%3D May 15 Rosenberg N, Yatuv R, Orion Y, et al. Glanzmann thrombasthenia caused by an 11.2-kb deletion in the glycoprotein IIIa (beta3) is a second mutation in Iraqi Jews that stemmed from a distinct founder. Blood 1997 May 15; 89(10): 3654–62
76. 76. L Li PF Bray 1993 Homologous recombination among three intragene Alu sequences causes an inversion-deletion resulting in the hereditary bleeding disorder Glanzmann thrombasthenia Am J Hum Genet 53 1 140 9 8317479 1:CAS:528:DyaK2cXhvVyltr4%3D Jul Li L, Bray PF. Homologous recombination among three intragene Alu sequences causes an inversion-deletion resulting in the hereditary bleeding disorder Glanzmann thrombasthenia. Am J Hum Genet 1993 Jul; 53(1): 140–9
77. 77. B Burwinkel MW Kilimann 1998 Unequal homologous recombination between LINE-1 elements as a mutational mechanism in human genetic disease J Mol Biol 277 3 513 7 9533876 1:CAS:528:DyaK1cXjtFKgsLs%3D 10.1006/jmbi.1998.1641 Apr 3 Burwinkel B, Kilimann MW. Unequal homologous recombination between LINE-1 elements as a mutational mechanism in human genetic disease. J Mol Biol 1998 Apr 3; 277(3): 513–7
78. 78. ML Huie AL Shanske JS Kasper 1999 A large Alu-mediated deletion, identified by PCR, as the molecular basis for glycogen storage disease type II (GSDII) Hum Genet 104 1 94 8 10071199 1:CAS:528:DyaK1MXmsVWhuw%3D%3D 10.1007/s004390050916 Jan Huie ML, Shanske AL, Kasper JS, et al. A large Alu-mediated deletion, identified by PCR, as the molecular basis for glycogen storage disease type II (GSDII). Hum Genet 1999 Jan; 104(1): 94–8
79. 79. Y Saikawa H Kaneda L Yue 2000 Structural evidence of genomic exon-deletion mediated by Alu-Alu recombination in a human case with heme oxygenase-1 deficiency Hum Mutat 16 2 178 9 10923045 1:STN:280:DC%2BD3cvjsFahsQ%3D%3D 10.1002/1098-1004(200008)16:2<178::AID-HUMU16>3.0.CO;2-X Aug Saikawa Y, Kaneda H, Yue L, et al. Structural evidence of genomic exon-deletion mediated by Alu-Alu recombination in a human case with heme oxygenase-1 deficiency. Hum Mutat 2000 Aug; 16(2): 178–9
80. 80. M Tosi 1998 Molecular genetics of C1 inhibitor Immunobiology 199 2 358 65 9777419 1:CAS:528:DyaK1cXmvFGmsrs%3D 10.1016/S0171-2985(98)80040-5 Aug Tosi, M. Molecular genetics of C1 inhibitor. Immunobiology 1998 Aug; 199(2): 358–65
81. 81. M Nystrom-Lahti P Kristo NC Nicolaides 1995 Founding mutations and Alu-mediated recombination in hereditary colon cancer Nat Med 1 11 1203 6 7584997 1:CAS:528:DyaK2MXptFahsLs%3D 10.1038/nm1195-1203 Nov Nystrom-Lahti M, Kristo P, Nicolaides NC, et al. Founding mutations and Alu-mediated recombination in hereditary colon cancer. Nat Med 1995 Nov; 1(11): 1203–6
82. 82. EM Brooks RF Branda JA Nicklas 2001 Molecular description of three macro-deletions and an Alu-Alu recombination-mediated duplication in the HPRT gene in four patients with Lesch-Nyhan disease Mutat Res 476 1–2 43 54 11336982 1:CAS:528:DC%2BD3MXjtFGhu7w%3D May 9 Brooks EM, Branda RF, Nicklas JA, et al. Molecular description of three macro-deletions and an Alu-Alu recombination-mediated duplication in the HPRT gene in four patients with Lesch-Nyhan disease. Mutat Res 2001 May 9; 476(1–2): 43–54
83. 83. J Rohrer Y Minegishi D Richter 1999 Unusual mutations in Btk: an insertion, a duplication, an inversion, and four large deletions Clin Immunol 90 1 28 37 9884350 1:CAS:528:DyaK1MXht1ynsr0%3D 10.1006/clim.1998.4629 Jan Rohrer J, Minegishi Y, Richter D, et al. Unusual mutations in Btk: an insertion, a duplication, an inversion, and four large deletions. Clin Immunol 1999 Jan; 90(1): 28–37
84. 84. B Morse PG Rotherg VJ South 1988 Insertional mutagenesis of the myc locus by a LINE-1 sequence in a human breast carcinoma Nature 333 6168 87 90 2834650 1:CAS:528:DyaL1cXks1Oqt78%3D 10.1038/333087a0 May 5 Morse B, Rotherg PG, South VJ, et al. Insertional mutagenesis of the myc locus by a LINE-1 sequence in a human breast carcinoma. Nature 1988 May 5; 333(6168): 87–90
85. 85. Y Miki I Nishisho A Horii 1992 Disruption of the APC gene by a retrotransposal insertion of L1 sequence in a colon cancer Cancer Res 52 3 643 5 1310068 1:CAS:528:DyaK38XhtVemsbg%3D Feb 1 Miki Y, Nishisho I, Horii A, et al. Disruption of the APC gene by a retrotransposal insertion of L1 sequence in a colon cancer. Cancer Res 1992 Feb 1; 52(3): 643–5
86. 86. NJ Samani JR Thompson L O’Toole 1996 A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction Circulation 94 4 708 12 8772692 1:STN:280:DyaK28zmvVKrtg%3D%3D 10.1161/01.CIR.94.4.708 Aug 15 Samani NJ, Thompson JR, O’Toole L, et al. A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction. Circulation 1996 Aug 15; 94(4): 708–12
87. 87. S Mustajoki H Ahola P Mustajoki 1999 Insertion of Alu element responsible for acute intermittent porphyria Hum Mutat 13 6 431 8 10408772 1:CAS:528:DyaK1MXktVKlsbg%3D 10.1002/(SICI)1098-1004(1999)13:6<431::AID-HUMU2>3.0.CO;2-Y Mustajoki S, Ahola H, Mustajoki P, et al. Insertion of Alu element responsible for acute intermittent porphyria. Hum Mutat 1999 13(6): 431–8
88. 88. B Knebelmann L Forestier L Drouot 1995 Splice-mediated insertion of an Alu sequence in the COL4A3 mRNA causing autosomal recessive Alport syndrome Hum Mol Genet 4 4 675 9 7633417 1:CAS:528:DyaK2MXltlSju7k%3D 10.1093/hmg/4.4.675 Apr Knebelmann B, Forestier L, Drouot L, et al. Splice-mediated insertion of an Alu sequence in the COL4A3 mRNA causing autosomal recessive Alport syndrome. Hum Mol Genet 1995 Apr; 4(4): 675–9
89. 89. M Oldridge EH Zackai DM McDonald-McGinn 1999 De novo alu-element insertions in FGFR2 identify a distinct pathological basis for Apert syndrome Am J Hum Genet 64 2 446 61 9973282 1:CAS:528:DyaK1MXhslOltLw%3D 10.1086/302245 Feb Oldridge M, Zackai EH, McDonald-McGinn DM, et al. De novo alu-element insertions in FGFR2 identify a distinct pathological basis for Apert syndrome. Am J Hum Genet 1999 Feb; 64(2): 446–61
90. 90. A Economou-Pachnis PN Tsichlis 1985 Insertion of an Alu SINE in the human homologue of the Mlvi-2 locus Nucleic Acids Res 13 23 8379 87 3001638 1:CAS:528:DyaL28Xot12htw%3D%3D 10.1093/nar/13.23.8379 Dec 9 Economou-Pachnis A, Tsichlis PN. Insertion of an Alu SINE in the human homologue of the Mlvi-2 locus. Nucleic Acids Res 1985 Dec 9; 13(23): 8379–87
91. 91. Y Miki T Katagiri F Kasumi 1996 Mutation analysis in the BRCA2 gene in primary breast cancers Nat Genet 13 2 245 7 8640237 1:CAS:528:DyaK28XktlOhu7w%3D 10.1038/ng0696-245 Jun Miki Y, Katagiri T, Kasumi F, et al. Mutation analysis in the BRCA2 gene in primary breast cancers. Nat Genet 1996 Jun; 13(2): 245–7
92. 92. T Wang I Lerer Z Gueta 2001 A deletion/insertion mutation in the BRCA2 gene in a breast cancer family: a possible role of the Alu-polyA tail in the evolution of the deletion Genes Chromosomes Cancer 31 1 91 5 11284040 1:CAS:528:DC%2BD3MXjt1Sqsr4%3D 10.1002/gcc.1110 May Wang T, Lerer I, Gueta Z, et al. A deletion/insertion mutation in the BRCA2 gene in a breast cancer family: a possible role of the Alu-polyA tail in the evolution of the deletion. Genes Chromosomes Cancer 2001 May; 31(1): 91–5
93. 93. KC Hailing CR Lazzaro R Honchel 1999 Hereditary desmoid disease in a family with a germline Alu I repeat mutation of the APC gene Hum Hered 49 2 97 102 10.1159/000022852 Mar Hailing KC, Lazzaro CR, Honchel R, et al. Hereditary desmoid disease in a family with a germline Alu I repeat mutation of the APC gene. Hum Hered 1999 Mar; 49(2): 97–102
94. 94. N Janicic Z Pausova DE Cole 1995 Insertion of an Alu sequence in the Ca(2+)-sensing receptor gene in familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism Am J Hum Genet 56 4 880 6 7717399 1:CAS:528:DyaK2MXlt1elsbc%3D Apr Janicic N, Pausova Z, Cole DE, et al. Insertion of an Alu sequence in the Ca(2+)-sensing receptor gene in familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Am J Hum Genet 1995 Apr; 56(4): 880–6
95. 95. GA Mitchell D Labuda G Fontaine 1991 Splice-mediated insertion of an Alu sequence inactivates ornithine delta-aminotransferase: a role for Alu elements in human mutation Proc Natl Acad Sci U S A 88 3 815 9 1992472 1:CAS:528:DyaK3MXhtFKhsr4%3D 10.1073/pnas.88.3.815 Feb 1 Mitchell GA, Labuda D, Fontaine G, et al. Splice-mediated insertion of an Alu sequence inactivates ornithine delta-aminotransferase: a role for Alu elements in human mutation. Proc Natl Acad Sci U S A 1991 Feb 1; 88(3): 815–9
96. 96. HH Kazazian Jr C Wong H Youssoufian 1988 Haemophilia A resulting from de novo insertion of L1 sequences represents a novel mechanism for mutation in man Nature 332 6160 164 6 2831458 1:CAS:528:DyaL1cXhvVWhu7s%3D 10.1038/332164a0 Mar 10 Kazazian Jr HH, Wong C, Youssoufian H, et al. Haemophilia A resulting from de novo insertion of L1 sequences represents a novel mechanism for mutation in man. Nature 1988 Mar 10; 332(6160): 164–6
97. 97. D Vidaud M Vidaud BR Bahnak 1993 Haemophilia B due to a de novo insertion of a human-specific Alu subfamily member within the coding region of the factor IX gene Eur J Hum Genet 1 1 30 6 8069649 1:CAS:528:DyaK3sXktVKhsbw%3D Vidaud D, Vidaud M, Bahnak BR, et al. Haemophilia B due to a de novo insertion of a human-specific Alu subfamily member within the coding region of the factor IX gene. Eur J Hum Genet 1993 1(1): 30–6
98. 98. YP Goldberg JM Rommens SE Andrew 1993 Identification of an Alu retro-transposition event in close proximity to a strong candidate gene for Huntington’s disease Nature 362 6418 370 3 8384324 1:CAS:528:DyaK3sXisFamur8%3D 10.1038/362370a0 Mar 25 Goldberg YP, Rommens JM, Andrew SE, et al. Identification of an Alu retro-transposition event in close proximity to a strong candidate gene for Huntington’s disease. Nature 1993 Mar 25; 362(6418): 370–3
99. 99. GB Hutchinson SE Andrew H McDonald 1993 An Alu element retroposition in two families with Huntington disease defines a new active Alu subfamily Nucleic Acids Res 21 15 3379 83 8393987 1:CAS:528:DyaK3sXmtVWjtL4%3D 10.1093/nar/21.15.3379 Jul 25 Hutchinson GB, Andrew SE, McDonald H, et al. An Alu element retroposition in two families with Huntington disease defines a new active Alu subfamily. Nucleic Acids Res 1993 Jul 25; 21(15): 3379–83
100. 100. R Vervoort R Gitzelmann W Lissens 1998 A mutation (IVS8+0.6kbdelTC) creating a new donor splice site activates a cryptic exon in an Alu-element in intron 8 of the human beta-glucuronidase gene Hum Genet 103 6 686 93 9921904 1:CAS:528:DyaK1cXnvFSjurk%3D Dec Vervoort R, Gitzelmann R, Lissens W, et al. A mutation (IVS8+0.6kbdelTC) creating a new donor splice site activates a cryptic exon in an Alu-element in intron 8 of the human beta-glucuronidase gene. Hum Genet 1998 Dec; 103(6): 686–93
101. 101. DE Cole N Janicic SR Salisbury 1997 Neonatal severe hyperparathyroidism, secondary hyperparathyroidism, and familial hypocalciuric hypercalcemia: multiple different phenotypes associated with an inactivating Alu insertion mutation of the calcium-sensing receptor gene Am J Med Genet 71 2 202 10 9217223 1:STN:280:DyaK2szmtVWqtw%3D%3D 10.1002/(SICI)1096-8628(19970808)71:2<202::AID-AJMG16>3.0.CO;2-I Aug 8 Cole DE, Janicic N, Salisbury SR, et al. Neonatal severe hyperparathyroidism, secondary hyperparathyroidism, and familial hypocalciuric hypercalcemia: multiple different phenotypes associated with an inactivating Alu insertion mutation of the calcium-sensing receptor gene. Am J Med Genet 1997 Aug 8; 71(2): 202–10
102. 102. MR Wallace LB Andersen AM Saulino 1991 A de novo Alu insertion results in neurofibromatosis type 1 Nature 353 6347 864 6 1719426 1:CAS:528:DyaK3MXmslansrs%3D 10.1038/353864a0 Oct 31 Wallace MR, Andersen LB, Saulino AM,et al. A de novo Alu insertion results in neurofibromatosis type 1. Nature 1991 Oct 31; 353(6347): 864–6
103. 103. Y Gu H Alder T Nakamura 1994 Sequence analysis of the breakpoint clusterregion in the ALL-1 gene involved in acute leukemia Cancer Res 54 9 2326 30 May 1 Gu Y, Alder H, Nakamura T, et al. Sequence analysis of the breakpoint clusterregion in the ALL-1 gene involved in acute leukemia. Cancer Res 1994 May 1; 54(9): 2326–30
104. 104. SP Sim LF Liu 2001 Nucleolytic cleavage of the MLL breakpoint cluster region (bcr) during apoptosis J Biol Chem 276 34 31590 5 11406628 1:CAS:528:DC%2BD3MXms1Snu70%3D 10.1074/jbc.M103962200 Sim SP, Liu LF. Nucleolytic cleavage of the MLL breakpoint cluster region (bcr) during apoptosis. J Biol Chem 2001; 276(34): 31590–5
105. 105. HG Super PL Strissel OM Sobulo 1997 Identification of complex genomic breakpoint junctions in the t(9;11) MLL-AF9 fusion gene in acute leukemia Genes Chromosomes Cancer 20 2 185 95 9331569 1:CAS:528:DyaK2sXmslygur8%3D 10.1002/(SICI)1098-2264(199710)20:2<185::AID-GCC9>3.0.CO;2-# Oct Super HG, Strissel PL, Sobulo OM, et al. Identification of complex genomic breakpoint junctions in the t(9;11) MLL-AF9 fusion gene in acute leukemia. Genes Chromosomes Cancer 1997 Oct; 20(2): 185–95